Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) went up by 86.67% from its latest closing price compared to the recent 1-year high of $4.25. The company’s stock price has collected -11.11% of loss in the last five trading sessions.
Is It Worth Investing in Sonoma Pharmaceuticals Inc. (NASDAQ :SNOA) Right Now?
Plus, the 36-month beta value for SNOA is at 1.05.
The average price from analysts is $9.00. SNOA currently public float of 3.09M and currently shorts hold a 1.65% ratio of that float. Today, the average trading volume of SNOA was 762.87K shares.
SNOA’s Market Performance
SNOA stocks went down by -11.11% for the week, with a monthly jump of 6.19% and a quarterly performance of -41.46%, while its annual performance rate touched -68.50%. The volatility ratio for the week stands at 8.57% while the volatility levels for the past 30 days are set at 8.36% for Sonoma Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is 90.48% for SNOA stocks with a simple moving average of -10.81% for the last 200 days.
SNOA Trading at 52.96% from the 50-Day Moving Average
After a stumble in the market that brought SNOA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.29% of loss for the given period.
Volatility was left at 8.36%, however, over the last 30 days, the volatility rate increased by 8.57%, as shares surge +89.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.37% upper at present.
During the last 5 trading sessions, SNOA rose by +73.03%, which changed the moving average for the period of 200-days by -35.69% in comparison to the 20-day moving average, which settled at $1.2275. In addition, Sonoma Pharmaceuticals Inc. saw 7.14% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SNOA
Current profitability levels for the company are sitting at:
- -46.62 for the present operating margin
- +31.62 for the gross margin
The net margin for Sonoma Pharmaceuticals Inc. stands at -40.28. Equity return is now at value -66.50, with -33.00 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.79.